Browsing by Author Ricke, Jens

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)Citation
2017First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trialsGebski, Val; et al, Various; Findlay, Michael; Gibbs, Peter; Heinemann, Volker; Peeters, Marc; Ricke, Jens; Sharma, Navesh K; Taieb, Julien; Wasan, Harpreet; Weaver, Andrew; NH&MRC Clinical Trials CentreFirst-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials, The Lancet Oncology, vol.18, 9, 2017,pp 1159-1171
2016SIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal CancerGebski, Val; et al, Various; Ferguson, Tom; Findlay, Michael; Hazel, Guy; Heinemann, Volker; Peeters, Marc; Perez, D; Ricke, Jens; Robinson, Bridget; Sharma, Navesh; Strickland, A. H.; NH&MRC Clinical Trials CentreSIRFLOX: Randomized Phase III Trial Comparing First-Line mFOLFOX6 (Plus or Minus Bevacizumab) Versus mFOLFOX6 (Plus or Minus Bevacizumab) Plus Selective Internal Radiation Therapy in Patients With Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.34, 15, 2016,pp 1723-1731